C. Angeletti

发表

Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.

A. Marchetti, N. Tinari, F. Buttitta, 2002, Cancer research.

Acute major airway injuries: clinical features and management.

C. Angeletti, A. Mussi, M. Ambrogi, 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer

C. Angeletti, G. Fontanini, A. Mussi, 2001, Oncogene.

Levels of p53 antigen in the serum of nonsmall cell lung-cancer patients correlate with positive p53 immunohistochemistry on tumor sections, tumor necrosis and nodal involvement.

C. Angeletti, G. Merlo, G. Fontanini, 1994, International journal of oncology.

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.

A. Chella, C. Angeletti, C. Tibaldi, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration

A. Whitworth, C. Angeletti, J. Gilley, 2019, Neurobiology of Disease.

Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration

A. Whitworth, C. Angeletti, J. Gilley, 2019, Neurobiology of Disease.

The management of malignant pericardial effusions using permanently implanted devices.

A. Chella, C. Angeletti, F. Melfi, 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Alterations of P16 (MTS1) in node‐positive non‐small cell lung carcinomas

A. Marchetti, F. Buttitta, A. Chella, 1997, The Journal of pathology.

FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K‐ras mutations

A. Marchetti, F. Buttitta, A. Chella, 1998, The Journal of pathology.

Early Operative Experience and Preliminary Clinical Results

C. Angeletti, F. Melfi, G. Menconi, 2002 .

Adrenal masses in non-small cell lung carcinoma patients: is there any role for laparoscopic procedures?

C. Angeletti, M. Lucchi, P. Miccoli, 1998, Journal of laparoendoscopic & advanced surgical techniques. Part A.

A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection.

A. Chella, C. Angeletti, M. Ambrogi, 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer.

A. Chella, C. Angeletti, G. Mariani, 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.

C. Angeletti, G. Fontanini, P. Macchiarini, 1993, The Journal of thoracic and cardiovascular surgery.

Paclitaxel/epirubicin/etoposide in patients with extensive-disease small-cell lung cancer (SCLC)

A. Chella, C. Angeletti, P. Conte, 1999 .

Surgery in the management of small cell lung cancer.

A. Chella, C. Angeletti, A. Mussi, 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Gamma Probe-Guided Thoracoscopic Surgery of Small Pulmonary Nodules

A. Chella, C. Angeletti, M. Ambrogi, 2000, Tumori.

Extended thymectomy in myasthenia gravis: a team-work of neurologist, thoracic surgeon and anaesthesist may improve the outcome.

C. Angeletti, L. Murri, A. Mussi, 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.

A. Marchetti, F. Buttitta, A. Chella, 1998, British Journal of Cancer.

mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations.

A. Marchetti, F. Buttitta, A. Chella, 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.

C. Angeletti, G. Fontanini, A. Mussi, 1995, British Journal of Cancer.

67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas.

C. Angeletti, S. Ménard, G. Fontanini, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K‐ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPE

A. Marchetti, F. Buttitta, A. Chella, 1996, The Journal of pathology.

Cyclin D1 and retinoblastoma susceptibility gene alterations in non‐small cell lung cancer

A. Marchetti, F. Buttitta, A. Chella, 1998, International journal of cancer.

Second primary lung cancer and relapse: treatment and follow-up.

A. Chella, C. Angeletti, G. Fontanini, 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma

C. Angeletti, G. Fontanini, A. Mussi, 2002, British Journal of Cancer.

Association between cigarette smoking and FHIT gene alterations in lung cancer.

A. Marchetti, F. Buttitta, A. Chella, 1997, Cancer research.

p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.

A. Marchetti, F. Buttitta, A. Chella, 1996, Oncogene.

Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients.

C. Angeletti, H. Bartsch, A. Mussi, 1990, Chest.

[Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].

A. Chella, C. Angeletti, A. Mussi, 1994, Minerva chirurgica.

The NAD+ precursor NMN activates dSarm to trigger axon degeneration in Drosophila

C. Angeletti, J. Gilley, M. Coleman, 2022, bioRxiv.

[The evaluation of the cardiotoxicity of 4'-epidoxorubicin at high doses].

C. Angeletti, P. Macchiarini, A. Balbarini, 1991, Cardiologia.

Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization

C. Angeletti, G. Fontanini, A. Mussi, 2000, British Journal of Cancer.

Treatment by VATS of giant bullous emphysema: results.

C. Angeletti, A. Mussi, M. Ambrogi, 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers.

C. Angeletti, H. Bartsch, P. Macchiarini, 1991, Carcinogenesis.

Surgical treatment of primary lung cancer and solitary brain metastasis.

C. Angeletti, A. Mussi, M. Pistolesi, 1985, Thorax.

Structure and catalytic activity of CoxMg1–xAl2O4 spinel solid solutions. Part 2.—Decomposition of N2O

C. Angeletti, P. Porta, F. Pepe, 1978 .

Quantitation by competitive PCR assay of vascular endothelial growth factor in non-small cell lung carcinomas.

C. Angeletti, G. Fontanini, A. Mussi, 1999, International journal of oncology.

Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.

A. Chella, C. Angeletti, C. Tibaldi, 1994, Seminars in oncology.

Phase II Study of High‐Dose Epirubicin in Untreated Patients with Small‐Cell Lung Cancer

A. Marchetti, C. Angeletti, P. Macchiarini, 1990, American journal of clinical oncology.

Endothoracic sonography with color Doppler availability during video assisted thoracic surgery (videothoracoscopic operative staging with ultrasound color Doppler) for lung cancer staging

C. Angeletti, M. Ambrogi, O. Goletti, 1998, Surgical Endoscopy.

A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus

C. Angeletti, E. Aronica, J. Wohlschlegel, 2020, The Journal of Biological Chemistry.

Surgery Plus Adjuvant Chemotherapy for T1–3N0M0 Small‐Cell Lung Cancer: Rationale for Current Approach

A. Chella, C. Angeletti, P. Macchiarini, 1991, American journal of clinical oncology.

Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia

C. Angeletti, P. Huppke, W. Brück, 2019, Experimental Neurology.

Programmed axon death executor SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated by physiological levels of NMN, NAD, NADP and other metabolites

C. Angeletti, J. Gilley, M. Coleman, 2021, bioRxiv.

Pulmonary LipidPeroxidation in Cigarette SmokersandLungCancerPatients

C. Angeletti, H. Bartsch, C. Giuntini, 2017 .

Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up

C. Angeletti, A. Mussi, M. Lucchi, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Structure and catalytic activity of CoχMg1–χAl2O4 spinel solid solutions. Part 1.—Cation distribution of Co2+ ions

C. Angeletti, P. Porta, F. Pepe, 1977 .

Systemic Melanoma Metastatic to the Retina and Vitreous

R. Mirimanoff, C. Angeletti, L. Zografos, 2004, Ophthalmologica.

Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg.

A. Chella, C. Angeletti, R. Danesi, 2003, The Journal of antimicrobial chemotherapy.

The Catalytic Activity of MgO, ZnO and their Solid Solutions for the Decomposition of N2O

C. Angeletti, M. Schiavello, A. Cimino, 1980 .

Catalytic behavior and surface chemistry of the ZnOAl203 system for the decomposition of 2-propanol

C. Angeletti, S. Rossi, F. Pepe, 1989 .

Catalytic behavior and surface chemistry of copper/alumina catalysts for isopropanol decomposition

C. Angeletti, M. Jacono, S. Rossi, 1985 .

Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence

C. Angeletti, R. Zhai, R. Hopkin, 2019, Experimental Neurology.

Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype.

C. Angeletti, G. Fontanini, A. Mussi, 1995, European journal of cancer.

Alterations in Non-Small Cell Lung Cancers Correlate with Metastatic Involvement of Hilar and Mediastinal Lymph Nodes 1

F. Buttitta, C. Angeletti, G. Merlo, 2006 .

p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.

A. Marchetti, F. Buttitta, A. Chella, 1993, Cancer research.

Prediction of Survival in Stage I Lung Carcinoma Patients by Telomerase Function Evaluation

A. Marchetti, F. Buttitta, A. Chella, 2002, Laboratory Investigation.

Relation of neovascularisation to metastasis of non-small-cell lung cancer

C. Angeletti, G. Fontanini, P. Macchiarini, 1992, The Lancet.

Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.

C. Angeletti, G. Fontanini, A. Mussi, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.

A. Marchetti, F. Buttitta, A. Chella, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.

C. Angeletti, G. Fontanini, A. Mussi, 2005, The Annals of thoracic surgery.

Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma.

C. Angeletti, G. Fontanini, A. Mussi, 1998, European journal of cancer.

Neoangiogenesis: A putative marker of malignancy in non‐small‐cell‐lung‐cancer (NSCLC) development

C. Angeletti, G. Fontanini, A. Mussi, 1996, International journal of cancer.

Functional results of bronchial sleeve lobectomy.

C. Angeletti, P. Macchiarini, G. Pistelli, 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Pre-breeding Diets in the Seahorse Hippocampus reidi: How Do They Affect Fatty Acid Profiles, Energetic Status and Histological Features in Newborn?

C. Angeletti, I. Olivotto, M. Planas, 2021, Frontiers in Marine Science.

Surgical approaches to membranous tracheal wall lacerations.

C. Angeletti, A. Mussi, M. Ambrogi, 2000, The Journal of thoracic and cardiovascular surgery.

Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.

C. Angeletti, G. Fontanini, A. Mussi, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.

C. Angeletti, G. Fontanini, A. Mussi, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.

C. Angeletti, G. Fontanini, A. Mussi, 1997, Journal of the National Cancer Institute.

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas

C. Angeletti, G. Fontanini, A. Mussi, 1999, British Journal of Cancer.

Influence of bulla volume on postbullectomy outcome.

C. Angeletti, A. Mussi, L. Carrozzi, 2001, Canadian respiratory journal.

The multimodality treatment of thymic carcinoma.

C. Angeletti, G. Fontanini, A. Mussi, 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Postintubation tracheal tear repair by cervicotomy and longitudinal tracheotomy.

C. Angeletti, A. Mussi, M. Ambrogi, 2000, The Annals of thoracic surgery.

Videothoracoscopy for evaluation and treatment of hemothorax.

C. Angeletti, A. Mussi, M. Ambrogi, 2002, Journal of Cardiovascular Surgery.

Results of EN Bloc Resections for Lung Cancer

C. Angeletti, A. Mussi, M. Miniati, 1984, Tumori.

Tumor angiogenesis and biologic markers in resected stage I NSCLC.

C. Angeletti, G. Fontanini, A. Mussi, 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (Stage IIIA‐N2): Impact of adjuvant therapies in a subset of patients at high risk of recurrence

A. Chella, C. Angeletti, G. Fontanini, 1996, Cancer.

Human non‐small cell lung cancer: P53 protein accumulation is an early event and persists during metastatic progression

C. Angeletti, G. Merlo, G. Fontanini, 1994, Journal of Pathology.

Late esophageal fistula complicating early postpneumonectomy empyema.

C. Angeletti, A. Janni, P. Magistrelli, 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Long-Lasting Effects of Tobacco Smoking on Pulmonary Drug-metabolizing Enzymes: A Case-Control Study on Lung Cancer Patients1

Gianfranco, C. Angeletti, H. Bartsch, 2006 .

Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.

C. Angeletti, L. Carrozzi, A. Aitio, 1988, Cancer research.

Effects of thymostimulin on chemotherapy-induced toxicity and long-term survival in small cell lung cancer patients.

C. Angeletti, P. Macchiarini, R. Danesi, 1989, Anticancer Research.

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.

C. Angeletti, G. Fontanini, A. Mussi, 1997, British Journal of Cancer.

Adjuvant chemotherapy for T1-2NOMO small cell lung cancer: single-agent or combination chemotherapy?

C. Angeletti, P. Macchiarini, F. Basolo, 1991, Cancer investigation.

Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma

A. Chella, C. Angeletti, P. Macchiarini, 1991, Cancer.

Microvessel count predicts metastatic disease and survival in non‐small cell lung cancer

A. Harris, C. Angeletti, G. Fontanini, 1995, The Journal of pathology.

Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors.

A. Chella, C. Angeletti, A. Mussi, 1996, The Journal of thoracic and cardiovascular surgery.

Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.

Gabriella, Alfredo, Silvana, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products.

C. Angeletti, G. Fontanini, A. Mussi, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.

C. Angeletti, G. Fontanini, P. Macchiarini, 1992, The Journal of thoracic and cardiovascular surgery.

Energy metabolism of thoracic surgical patients in the early postoperative period. Effect of posture.

C. Angeletti, L. S. Brandi, R. Bertolini, 1996, Chest.

Surgical treatment of bullous lung disease

C. Angeletti, A. Mussi, A. Ribechini, 1994 .

Small cell lung carcinoma (SCLC): the angiogenic phenomenon.

C. Angeletti, G. Fontanini, A. Mussi, 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Early experience with robotic technology for thoracoscopic surgery.

C. Angeletti, F. Melfi, Franca M A Melfi, 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Gastropleural fistula as complication of postpneumonectomy empyema.

C. Angeletti, A. Mussi, M. Lucchi, 2000, The Journal of cardiovascular surgery.

Thymic carcinoma: a report of 13 cases.

C. Angeletti, G. Fontanini, A. Mussi, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer.

A. Chella, C. Angeletti, A. Mussi, 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Results of treatment and lessons learned from pathologically staged T4 non‐small cell lung cancer

A. Chella, C. Angeletti, P. Macchiarini, 1991, Journal of surgical oncology.

p53 expression in non small cell lung cancer: clinical and biological correlations.

C. Angeletti, G. Fontanini, P. Macchiarini, 1993, Anticancer research.

The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node‐negative non‐small cell lung cancer

C. Angeletti, G. Fontanini, P. Macchiarini, 1992, Cancer.

Soil organic matter content and chemical composition under two rotation management systems in a Mediterranean climate

C. Angeletti, C. Vischetti, Beatrice Giannetta, 2021 .

Author response: Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1

C. Angeletti, L. Hartley-Tassell, B. Kobe, 2021 .

Results and prognostic factors of surgery in the management of non‐small cell lung cancer with solitary brain metastasis

C. Angeletti, M. Burt, P. Macchiarini, 1991, Cancer.

Mediastinal Goitres : when the Transthoracic Approach?

C. Angeletti, A. Mussi, M. Ambrogi, 2000, Acta chirurgica Belgica.

The utility of polyglactin-910 mesh in the plastic reconstruction of the chest wall after en-bloc resection.

C. Angeletti, M. Lucchi, G Menconi, 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Potent activation of SARM1 by NMN analogue VMN underlies vacor neurotoxicity

C. Angeletti, J. Gilley, M. Coleman, 2020 .

Percutaneous radiofrequency ablation of stage IA non-small cell lung cancer: A prospective multicenter clinical trial.

C. Angeletti, C. Bartolozzi, R. Suh, 2004, Journal of Clinical Oncology.

Thymomas: clinical-pathological correlations.

C. Angeletti, G. Fontanini, A. Mussi, 2006, The Journal of cardiovascular surgery.

Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer.

C. Angeletti, G. Fontanini, A. Mussi, 2002, International journal of oncology.

Radiofrequency Ablation of Lung Malignancies: Where Do We Stand?

C. Angeletti, G. Fontanini, C. Bartolozzi, 2004, CardioVascular and Interventional Radiology.

Thymectomy in ocular myasthenia gravis.

C. Angeletti, A. Mussi, M. Lucchi, 2003, The Journal of thoracic and cardiovascular surgery.

Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study.

M. Fabrini, A. Chella, C. Angeletti, 2000, Lung cancer.

Posterior wall laceration of the thoracic trachea: the transcervical-transtracheal approach.

C. Angeletti, A. Mussi, M. Ambrogi, 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Genetic and morphological variation of Rhizophora mangle (red mangrove) along the northern Pacific coast of Nicaragua

C. Angeletti, F. Bagnoli, P. Bruschi, 2014 .

Influence of T and N stages on long-term survival in resectable small cell lung cancer.

C. Angeletti, P. Macchiarini, A. Mussi, 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Optimal treatment for T1-3NOMO small cell lung cancer: surgery plus adjuvant chemotherapy.

C. Angeletti, P. Macchiarini, A. Mussi, 1989, Anticancer research.

Modulation of neoangiogenesis in bronchial preneoplastic lesions.

C. Angeletti, G. Fontanini, A. Mussi, 1999, Oncology reports.

Phase II Feasibility Study of High Dose Epirubicin‐based Regimens for Untreated Patients with Small‐Cell Lung Cancer

A. Chella, C. Angeletti, P. Macchiarini, 1990, American journal of clinical oncology.

Neo-Adjuvant chemotherapy for invasive thymoma: an interim analysis

A. Chella, C. Angeletti, P. Macchiarini, 1991 .

Low-toxic combination chemotherapy for limited small-cell lung cancer

C. Angeletti, P. Macchiarini, R. Danesi, 1989 .

Penetration of clofoctol into human lung.

C. Angeletti, R. Danesi, S. Senesi, 1987, The Journal of antimicrobial chemotherapy.

A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay.

C. Angeletti, R. Danesi, S. Senesi, 1988, Drugs under experimental and clinical research.

Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.

A. Marchetti, F. Buttitta, A. Chella, 1999, Clinical Cancer Research.